Xcout IntelSign inSubscribe

TEVA

TEVAPharmaceuticalsTel Aviv, Israel

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.

Subscribe to see TEVA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

TEVA at a glance

TEVA is a pharmaceuticals company headquartered in Tel Aviv, Israel. It is publicly listed (TEVA) with a market capitalisation of $45.8B. Xcout tracks 20 named people at TEVA, including Richard Francis (President, Chief Executive Officer & Director). Xcout recorded 1 job posting from TEVA in the last 90 days.

Industry
Pharmaceuticals
Headquarters
Tel Aviv, Israel
Market cap
$45.8B
Employees
37,000
Ticker
TEVA
Job postings recorded (90 days)
1

TEVA leadership

  • Richard FrancisPresident, Chief Executive Officer & Director
  • Eliyahu Sharon KalifExecutive Vice President & Chief Financial Officer
  • Eli KalifChief Financial Officer
  • Eric A. HughesExecutive Vice President of Global R&D and Chief Medical Officer
  • Amir WeissSenior Vice President & Chief Accounting Officer
  • Brian SavageInterim Chief Legal Officer

14 more named people on record for TEVA, with roles, board committees and tenure — see the full roster →

Hiring at TEVA

Xcout recorded 1 job posting from TEVA in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see TEVA's hiring signals →

Recent TEVA news

4 corporate events on record, with sources — see the full timeline →

TEVA competitors

A few of TEVA's closest competitors — see the full list of competitors and alternatives →

Bausch Health Companies Inc.BHC · PharmaceuticalsLaval, Canada
63% matchPublic

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Market cap$1.8B
Employees20,300
Bausch Health Companies Inc. competitors & alternatives →

Get TEVA's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

TEVA — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on TEVA in Xcout Intel

  • 20 named people with titles, LinkedIn and board committees
  • Weekly hiring history and the mix of roles behind it
  • 4 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →